{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:54:38Z","timestamp":1787774078648,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Increased fasting plasma glucose (FPG), which includes impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and diabetes, is a risk factor for arterial stiffness. While IFG is widely accepted as a cardiovascular risk factor, recent studies have argued that subjects with high-normal glucose level were characterized by a high incidence of cardiovascular disease. The purpose of this study is to investigate the relationship between FPG and arterial stiffness in non-diabetic healthy subjects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We recruited 697 subjects who visited the health promotion center of a university hospital from May 2007 to August 2008. Age, sex, body mass index (BMI), resting heart rate, smoking habits, alcohol intake, exercise, blood pressure, medical history, FPG, lipid profile, high sensitivity C-reactive protein (hs-CRP), and Brachial-ankle pulse wave velocity (ba-PWV) were measured. We performed correlation and multiple linear regression analyses to divide the research subjects into quartiles: Q1(n = 172), 65 mg\/dL \u2264FPG &lt; 84 mg\/dL; Q2(n = 188), 84 mg\/dL \u2264FPG &lt; 91 mg\/dl; Q3(n = 199), 91 mg\/dL \u2264FPG &lt; 100 mg\/dL; Q4(n = 138), 100 mg\/dL \u2264FPG &lt; 126 mg\/dL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>FPG has an independent, positive association with ba-PWV in non-diabetic subjects after correcting for confounding variables, including age, sex, BMI, blood pressure, resting heart rate, hs-CRP, lipid profile, and behavioral habits. The mean ba-PWV of the high-normal glucose group (Q3, 1384 cm\/s) was higher than that of the low-normal glucose group (1303 \u00b1 196 cm\/s vs.1328 \u00b1 167 cm\/s, P &lt; 0.05). The mean ba-PWV value in the IFG group (1469 \u00b1 220 cm\/s) was higher than that in the normoglycemic group (P &lt; 0.05, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>An increase in FPG, even within the normal range, was associated with aggravated arterial stiffness. Further research is needed to determine the glycemic target value for the prevention of arterial stiffness in clinical and public health settings.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1475-2840-10-30","type":"journal-article","created":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T18:49:12Z","timestamp":1305830952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes"],"prefix":"10.1186","volume":"10","author":[{"given":"Jin Young","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Ree","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,15]]},"reference":[{"key":"341_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/dmrr.1086","volume":"26","author":"E Lukich","year":"2010","unstructured":"Lukich E, Matas Z, Boaz M, Shargorodsky M: Increasing derangement of glucose homeostasis is associated with increased arterial stiffness in patients with diabetes, impaired fasting glucose and normal controls. Diabetes Metab Res Rev. 2010, 26: 365-70. 10.1002\/dmrr.1086.","journal-title":"Diabetes Metab Res Rev"},{"key":"341_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2337\/diacare.22.3.399","volume":"22","author":"JE Shaw","year":"1999","unstructured":"Shaw JE, Zimmet PZ, De Courten M, Dowse GK, Chitson P, Gareeboo H, Hamraj F, Fareed D, Tuomilehto J, Alberti KG: Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?. Diabetes Care. 1999, 22: 399-402. 10.2337\/diacare.22.3.399.","journal-title":"Diabetes Care"},{"key":"341_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00125-007-0918-3","volume":"51","author":"CD Stehouwer","year":"2008","unstructured":"Stehouwer CD, Henry RM, Ferreira I: Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008, 51: 527-539. 10.1007\/s00125-007-0918-3.","journal-title":"Diabetologia"},{"key":"341_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1475-2840-8-52","volume":"8","author":"J Escobedo","year":"2009","unstructured":"Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R, Torres M, Hernandez R, Wilson E: Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol. 2009, 8: 52-10.1186\/1475-2840-8-52.","journal-title":"Cardiovasc Diabetol"},{"key":"341_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2337\/diacare.23.1.34","volume":"23","author":"JE Shaw","year":"2000","unstructured":"Shaw JE, Zimmet PZ, Hodge AM, de Courten M, Dowse GK, Chitson P, Tuomilehto J, Alberti KG: Impaired fasting glucose: how low should it go?. Diabetes Care. 2000, 23: 34-39. 10.2337\/diacare.23.1.34.","journal-title":"Diabetes Care"},{"key":"341_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1210\/jcem-42-2-222","volume":"42","author":"JD Brunzell","year":"1976","unstructured":"Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte D: Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab. 1976, 42: 222-229. 10.1210\/jcem-42-2-222.","journal-title":"J Clin Endocrinol Metab"},{"key":"341_CR7","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(05)65719-4","volume":"348","author":"MA Charles","year":"1996","unstructured":"Charles MA, Balkau B, Vauzelle-Kervroedan F, Thibult N, Eschwege E: Revision of diagnostic criteria for diabetes. Lancet. 1996, 348: 1657-1658. 10.1016\/S0140-6736(05)65719-4.","journal-title":"Lancet"},{"key":"341_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.2337\/diacare.22.8.1339","volume":"22","author":"E Bonora","year":"1999","unstructured":"Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna R, Muqqeo M: Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care. 1999, 22: 1339-1346. 10.2337\/diacare.22.8.1339.","journal-title":"Diabetes Care"},{"key":"341_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/01.HYP.0000198539.34501.1a","volume":"47","author":"H Tomiyama","year":"2006","unstructured":"Tomiyama H, Hashimoto H, Hirayama Y, Yambe M, Yamada J, Koji Y, Shiina K, Yamamoto Y, Yamashina A: Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension. 2006, 47: 180-188. 10.1161\/01.HYP.0000198539.34501.1a.","journal-title":"Hypertension"},{"key":"341_CR10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0002-9149(00)01118-8","volume":"86","author":"CM Alexander","year":"2000","unstructured":"Alexander CM, Landsman PB, Teutsch SM: Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol. 2000, 86: 897-902. 10.1016\/S0002-9149(00)01118-8.","journal-title":"Am J Cardiol"},{"key":"341_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0140-6736(99)00179-8","volume":"354","author":"ED Lehmann","year":"1999","unstructured":"Lehmann ED: Clinical value of aortic pulse-wave velocity measurement. Lancet. 1999, 354: 528-529. 10.1016\/S0140-6736(99)00179-8.","journal-title":"Lancet"},{"key":"341_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0895-7061(03)00918-X","volume":"16","author":"M Munakata","year":"2003","unstructured":"Munakata M, Ito N, Nunokawa T, Yoshinaga K: Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens. 2003, 16: 653-657. 10.1016\/S0895-7061(03)00918-X.","journal-title":"Am J Hypertens"},{"key":"341_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2337\/diacare.26.2.437","volume":"26","author":"H Ohnish","year":"2003","unstructured":"Ohnish H, Isobe T, Saitoh S, Kikuchi Y, Takagi S, Takeuchi H, Shimamoto K: Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose. Diabetes Care. 2003, 26: 437-440. 10.2337\/diacare.26.2.437.","journal-title":"Diabetes Care"},{"key":"341_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1291\/hypres.26.615","volume":"26","author":"A Yamashina","year":"2003","unstructured":"Yamashina A, Tomiyama H, Arai T, Hirose K, Yutaka K, Hirayama Y, Yamamoto Y, Hori S: Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res. 2003, 26: 615-622. 10.1291\/hypres.26.615.","journal-title":"Hypertens Res"},{"issue":"Suppl 1","key":"341_CR15","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.2337\/dc08-S055","volume":"31","author":"American Diabetes Association","year":"2008","unstructured":"American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008, 31 (Suppl 1): S55-S60.","journal-title":"Diabetes Care"},{"key":"341_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/archinte.161.11.1413","volume":"161","author":"Y Cui","year":"2001","unstructured":"Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL: Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001, 161: 1413-1419. 10.1001\/archinte.161.11.1413.","journal-title":"Arch Intern Med"},{"key":"341_CR17","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1161\/CIRCULATIONAHA.104.532499","volume":"112","author":"T Pischon","year":"2005","unstructured":"Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB: Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation. 2005, 112: 3375-3383. 10.1161\/CIRCULATIONAHA.104.532499.","journal-title":"Circulation"},{"key":"341_CR18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2265.2007.02780.x","volume":"66","author":"JW Lee","year":"2007","unstructured":"Lee JW, Lee HR, Shim JY, Im JA, Kim SH, Choi H, Lee DC: Viscerally obese women with normal body weight have greater brachial-ankle pulse wave velocity than nonviscerally obese women with excessive body weight. Clin Endocrinol (Oxf). 2007, 66: 572-578.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"341_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1291\/hypres.25.359","volume":"25","author":"A Yamashina","year":"2002","unstructured":"Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002, 25: 359-364. 10.1291\/hypres.25.359.","journal-title":"Hypertens Res"},{"key":"341_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.acvd.2010.03.004","volume":"103","author":"BJ Park","year":"2010","unstructured":"Park BJ, Lee HR, Shim JY, Lee JH, Jung DH, Lee YJ: Association between resting heart rate and arterial stiffness in Korean adults. Arch Cardiovasc Dis. 2010, 103: 246-52. 10.1016\/j.acvd.2010.03.004.","journal-title":"Arch Cardiovasc Dis"},{"key":"341_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/dmrr.1059","volume":"26","author":"L Xu","year":"2010","unstructured":"Xu L, Jiang CQ, Lam TH, Yue XJ, Cheng KK, Liu B, Jin YL, Zhang WS, Thomas GN: Brachial-ankle pulse wave velocity and cardiovascular risk factors in the non-diabetic and newly diagnosed diabetic Chinese: Guangzhou Biobank Cohort Study-CVD. Diabetes Metab Res Rev. 2010, 26: 133-139. 10.1002\/dmrr.1059.","journal-title":"Diabetes Metab Res Rev"},{"key":"341_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/01.ATV.0000118015.26978.07","volume":"24","author":"GN Thomas","year":"2004","unstructured":"Thomas GN, Chook P, Qiao M, Huang XS, Leong HC, Celermajer DS, Woo KS: Deleterious impact of \"high normal\" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol. 2004, 24: 739-743. 10.1161\/01.ATV.0000118015.26978.07.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"341_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2337\/diacare.22.1.45","volume":"22","author":"JV Bjornholt","year":"1999","unstructured":"Bjornholt JV, Erikssen G, Aaser E, Sandvik L, Nitter-Hauge S, Jervell J, Erikssen J, Thaulow E: Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes care. 1999, 22: 45-49. 10.2337\/diacare.22.1.45.","journal-title":"Diabetes care"},{"key":"341_CR24","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S0735-1097(98)00637-8","volume":"33","author":"HC Gerstein","year":"1999","unstructured":"Gerstein HC, Pais P, Pogue J, Yusuf S: Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study. J Am Coll Cardiol. 1999, 33: 612-619. 10.1016\/S0735-1097(98)00637-8.","journal-title":"J Am Coll Cardiol"},{"key":"341_CR25","doi-asserted-by":"publisher","first-page":"946","DOI":"10.2337\/db08-1192","volume":"58","author":"P Rerkpattanapipat","year":"2009","unstructured":"Rerkpattanapipat P, D'Agostino RB, Link KM, Shahar E, Lima JA, Bluemke DA, Herrington DM, Hundley WG: Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the Multi-Ethnic Study of Atherosclerosis. Diabetes. 2009, 58: 946-953. 10.2337\/db08-1192.","journal-title":"Diabetes"},{"key":"341_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1046\/j.1464-5491.2002.00835.x","volume":"19","author":"N Unwin","year":"2002","unstructured":"Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002, 19: 708-723. 10.1046\/j.1464-5491.2002.00835.x.","journal-title":"Diabet Med"},{"key":"341_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5551\/jat.5686","volume":"18","author":"CT Ho","year":"2011","unstructured":"Ho CT, Lin CC, Hsu HS, Liu CS, Davidson LE, Li TC, Li CI, Lin WY: Arterial Stiffness is Strongly Associated with Insulin Resistance in Chinese -A Population-Based Study (Taichung Community Health Study, TCHS). J Atheroscler Thromb. 2011, 18: 122-30.","journal-title":"J Atheroscler Thromb"},{"key":"341_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/hr.2010.234","volume":"34","author":"H Okada","year":"2011","unstructured":"Okada H, Fukui M, Tanaka M, Akabame S, Tomiyasu K, Nakano K, Yamazaki M, Hasegawa G, Oda Y, Nakamura N: Low insulin level is associated with aortic stiffness. Hypertens Res. 2011, 34: 336-40. 10.1038\/hr.2010.234.","journal-title":"Hypertens Res"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-10-30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T21:44:56Z","timestamp":1712439896000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-10-30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,15]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["341"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-10-30","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,15]]},"assertion":[{"value":"5 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"30"}}